Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention relates to peptides comprising lysine, alanine, leucine and valine, pharmaceutical compositions comprising same, and uses thereof for treating inflammatory conditions and allergy.
BACKGROUND OF THE INVENTION
Antimicrobial Peptides
Lipopolysaccharides
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This invention relates to compounds particularly for use in the autoimmune inflammatory disease and specifically the treatment of inflammatory bowel disease.
INTRODUCTION
Cytokines can be produced by various cell populations and have been shown to augment or limit immune responses to pathogens and
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
1. FIELD OF THE INVENTION
This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which has been identified as an
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention relates to peptides having anti-inflammatory properties. In particular, the present invention relates to peptides through actions on cells that modify the leukocyte recruitment and activation cascade and the actions of mediators released from inflammatory
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
This invention concerns a new family of peptide molecules having the capacity especially of stimulating the expression of the cytokines of inflammation and promoting regeneration of tissues. The invention, thus, also pertains to pharmaceutical compositions containing at least
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND OF THE INVENTION
The present invention relates to cyclosporin derivatives, their production and their use for therapy.
The cyclosporins comprise a group of cyclic, poly-N-methylated undecapeptides having valuable therapeutic properties, particularly as immunosuppressive and
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The present invention relates to peptides, their production and their use for therapy.
The cyclosporins comprise a group of cyclic, poly-N-methylated undecapeptides having valuable therapeutic properties, particularly as immunosuppressive and anti-inflammatory agents although it has been suggested
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
This invention relates to the discovery that certain latent isocyanate derivatives are capable of irreversibly deactivating the proteolytic enzyme human leukocyte elastase (HLE). The inhibitors of this invention have been found to bond to primary specificity sites to thereby irreversibly eliminate
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
BACKGROUND
Undesired weight loss, particularly lean mass loss is a relatively common occurrence in critical illness, and has a significant impact on morbidity and mortality. This is particularly true in cancer patients, where such mass losses can become treatment-limiting, and thus impact overall
Samo registrirani uporabniki lahko prevajajo članke
Prijava / prijava
FIELD OF THE INVENTION
The present invention relates generally to topically applicable pharmaceutical and cosmetic compositions, and more particularly, to compositions containing specific mixtures of amino acids and vitamins.
BACKGROUND OF THE INVENTION
The stratum corneum or horny layer of the
Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo
Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti
Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja. * Vse informacije temeljijo na objavljenih znanstvenih raziskavah